Xinxin Deng
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
-
- Pancreatic and Hepatic Oncology Research
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Cancer, Lipids, and Metabolism 3
-
- Atherosclerosis and Cardiovascular Diseases 4
Xinxin Deng
33 papers receiving 500 citations
Peers
Comparison fields: 5 of 104
- Cancer Research 93
- Oncology 110
- Pharmacology 53
- Immunology 66
- Pharmacology 27
Countries citing papers authored by Xinxin Deng
This map shows the geographic impact of Xinxin Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxin Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxin Deng more than expected).
Fields of papers citing papers by Xinxin Deng
This network shows the impact of papers produced by Xinxin Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxin Deng. The network helps show where Xinxin Deng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinxin Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 7 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 102 | |
| 14 | 2019 | 5 | |
| 15 | 2019 | 20 | |
| 16 | 2018 | 22 | |
| 17 | 2013 | 31 | |
| 18 | 2012 | 9 | |
| 19 | 2010 | 6 | |
| 20 | Studies of CRP Levels and CRP Gene Polymorphism rs1205 in Type 2 Diabetes Mellitus Patients | 2009 | 1 |
About Xinxin Deng
Xinxin Deng is a scholar working on Cancer Research, Immunology, Oncology, Pharmacology and Pharmacology, having authored 36 papers that have together received 504 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (4 papers), Phytochemistry and Bioactive Compounds (3 papers), Cancer, Lipids, and Metabolism (3 papers), RNA modifications and cancer (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Ferroptosis and cancer prognosis (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Cancer Research (93 citations), Oncology (110 citations), Pharmacology (53 citations), Immunology (66 citations) and Pharmacology (27 citations). Xinxin Deng has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Changcai Bai, Ruizhou Wang, Huifeng Hao, Lu Han, Yanna Jiao, Xinyu Wen, Shuyan Han, Feng Gu, Xingwang Jia and Rongrong Zhou. Their work appears in journals such as Journal of Ethnopharmacology, Phytomedicine, Vehicular Communications, Forests and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.